Pirnabine

Pirnabine (SP-304) is a synthetic cannabinoid receptor ligand, which was developed for the treatment of glaucoma.[1]

Pirnabine
Identifiers
  • (3,6,6,9-Tetramethyl-7,8,9,10-tetrahydrobenzo[c]chromen-1-yl) acetate
CAS Number
PubChem CID
ChemSpider
UNII
Chemical and physical data
FormulaC19H24O3
Molar mass300.398 g·mol−1
3D model (JSmol)
  • O=C(C)Oc1cc(C)cc(OC2(C)C)c1C(C3)=C2CCC3C
  • InChI=1S/C19H24O3/c1-11-6-7-15-14(8-11)18-16(21-13(3)20)9-12(2)10-17(18)22-19(15,4)5/h9-11H,6-8H2,1-5H3
  • Key:AADNQNOXNWEYHS-UHFFFAOYSA-N
  (verify)


References
  1. "New Names". JAMA: The Journal of the American Medical Association. 241: 65. 1979. doi:10.1001/jama.1979.03290270051024.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.